MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS

[1]  U. Förstermann,et al.  Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. , 2013, Nitric oxide : biology and chemistry.

[2]  S. Tavazoie,et al.  Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis , 2012, Cell.

[3]  Savita Khanna,et al.  The MicroRNA miR-199a-5p Down-regulation Switches on Wound Angiogenesis by Derepressing the v-ets Erythroblastosis Virus E26 Oncogene Homolog 1-Matrix Metalloproteinase-1 Pathway* , 2012, The Journal of Biological Chemistry.

[4]  F. Xue,et al.  Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. , 2012, Biochemical and biophysical research communications.

[5]  Y. Ouchi,et al.  Sirtuin 1 Retards Hyperphosphatemia-Induced Calcification of Vascular Smooth Muscle Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Tin-Lap Lee,et al.  Methylation of an intronic region regulates miR-199a in testicular tumor malignancy , 2011, Oncogene.

[7]  P. Caposio,et al.  The role of cytomegalovirus in angiogenesis. , 2011, Virus Research.

[8]  C. Paulus,et al.  Human Cytomegalovirus IE1 Protein Elicits a Type II Interferon-Like Host Cell Response That Depends on Activated STAT1 but Not Interferon-γ , 2011, PLoS pathogens.

[9]  Yutaka Tsutsumi,et al.  MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers. , 2011, Cancer research.

[10]  C. Matter,et al.  Protective roles of SIRT1 in atherosclerosis , 2011, Cell cycle.

[11]  P. Caposio,et al.  IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. , 2011, Blood.

[12]  G. Gerken,et al.  Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion , 2010, Molecular Cancer.

[13]  Y. Ouchi,et al.  SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. , 2010, Journal of atherosclerosis and thrombosis.

[14]  B. Becher,et al.  SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis , 2009, European heart journal.

[15]  I. Komuro,et al.  Protective Role of SIRT1 in Diabetic Vascular Dysfunction , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[16]  S. Vatner,et al.  Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes , 2009, Circulation research.

[17]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[18]  De-Pei Liu,et al.  Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. , 2008, Cardiovascular research.

[19]  S. Dimmeler,et al.  Emerging roles of SIRT1 in vascular endothelial homeostasis , 2008, Cell cycle.

[20]  R. de Cabo,et al.  Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. , 2008, American journal of physiology. Heart and circulatory physiology.

[21]  Richard D. Smith,et al.  Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing , 2008, Journal of Virology.

[22]  G. L. Bentz,et al.  Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and β1 and β3 integrins , 2008, Proceedings of the National Academy of Sciences.

[23]  F. Alt,et al.  SIRT1 controls endothelial angiogenic functions during vascular growth. , 2007, Genes & development.

[24]  Cuk-Seong Kim,et al.  SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase , 2007, Proceedings of the National Academy of Sciences.

[25]  P. Caposio,et al.  Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. , 2007, Antiviral research.

[26]  L. Guarente,et al.  SIRT1 Inhibits Transforming Growth Factor β-Induced Apoptosis in Glomerular Mesangial Cells via Smad7 Deacetylation* , 2007, Journal of Biological Chemistry.

[27]  C. Söderberg-Nauclér,et al.  Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? , 2006, Journal of internal medicine.

[28]  J. Coselli,et al.  Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). , 2006, Cardiovascular research.

[29]  D. Wink,et al.  Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[31]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[32]  H. Valantine.  The Role of Viruses in Cardiac Allograft Vasculopathy , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  G. Ridgway,et al.  Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function , 2003, Circulation.

[34]  M. Simons,et al.  Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. , 2003, Trends in cardiovascular medicine.

[35]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[36]  T. Katagiri,et al.  The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation , 2001, Histochemistry and Cell Biology.

[37]  D. Streblow,et al.  Do pathogens accelerate atherosclerosis? , 2001, The Journal of nutrition.

[38]  Guoyao Wu,et al.  Tetrahydrobiopterin levels regulate endothelial cell proliferation. , 2001, American journal of physiology. Heart and circulatory physiology.

[39]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[40]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[41]  M. Billingham.  Histopathology of graft coronary disease. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  P. Libby,et al.  Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. , 1989, Transplantation proceedings.

[43]  Xu Wang,et al.  SIRT1 suppresses PMA and ionomycin-induced ICAM-1 expression in endothelial cells , 2012, Science China Life Sciences.

[44]  M. Cheeran,et al.  Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: Antiviral implications , 2011, Journal of NeuroVirology.

[45]  A. Moses,et al.  Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. , 2008, Current topics in microbiology and immunology.

[46]  J. Hosenpud,et al.  Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.